Peripheral Nerve Stimulators Market Report 2025

This Peripheral Nerve Stimulators market report delivers an in-depth analysis of the market’s key characteristics, including size, growth potential, and segmentation. It provides a detailed breakdown of the market across major regions and leading countries, highlighting historical data and future growth projections. The report also examines the competitive landscape, market share insights, emerging trends, and strategic developments shaping the market.

The peripheral nerve stimulators market size has grown strongly in recent years. It will grow from $0.7 billion in 2024 to $0.77 billion in 2025 at a compound annual growth rate (CAGR) of 9.35%. The growth during the historic period was driven by the increasing demand for non-pharmacological pain management solutions, rising awareness about alternative pain relief therapies, the growing adoption of minimally invasive procedures, an expanding geriatric population, and the proliferation of pain management clinics.

The peripheral nerve stimulators market size is expected to see strong growth in the next few years. It will grow to $1.08 billion in 2029 at a compound annual growth rate (CAGR) of 8.98%. In the forecast period, growth is expected to be fueled by favorable government regulations and initiatives, a growing preference for outpatient and home-based treatments, an expanding number of pain management clinics, increasing demand for customized peripheral nerve stimulator (PNS) devices, and improvements in healthcare infrastructure. Key trends anticipated include the development of wireless PNS devices, integration of mobile apps for remote monitoring of PNS systems, the emergence of wearable and non-invasive PNS devices, and the introduction of advanced PNS systems featuring AI-powered pain management capabilities.

The rising prevalence of neurological disorders is driving the growth of the peripheral nerve stimulators market. Neurological disorders, including conditions such as Alzheimer's disease, Parkinson's disease, and chronic neuropathic pain, are becoming increasingly common due to aging populations, lifestyle factors, and improved diagnostic capabilities. Peripheral nerve stimulators offer an innovative solution by providing targeted electrical stimulation to manage chronic pain, restore motor function, and facilitate nerve regeneration. For instance, in March 2023, the Alzheimer's Association reported that approximately 6.7 million Americans aged 65 and older were living with Alzheimer's dementia, with the number expected to nearly double by 2060. This increasing burden of neurological conditions is fueling demand for advanced therapeutic options such as peripheral nerve stimulators.

Companies in the peripheral nerve stimulators market are focusing on the development of ultra-miniaturized systems to enhance patient care. These systems are characterized by their compact size, minimal invasiveness, and advanced functionality. For example, in April 2023, NeuSpera Medical Inc. received FDA clearance for its next-generation ultra-miniaturized system for managing chronic peripheral nerve pain. This system eliminates traditional leads, reducing complications and promoting faster recovery times. Its micro-implant design ensures precise nerve stimulation, offering long-term relief for patients with chronic nerve pain. This innovation highlights the growing trend toward more patient-friendly, minimally invasive devices with enhanced therapeutic outcomes.

In November 2023, Boston Scientific Corporation acquired Relievant Medsystems Inc. for $850 million to expand its pain management portfolio. Relievant’s expertise in spinal nerve stimulation, particularly for vertebrogenic chronic back pain, complements Boston Scientific’s existing offerings. This acquisition underscores the increasing focus on minimally invasive treatments and highlights the growing market potential for advanced peripheral nerve stimulation technologies.

Major players in the peripheral nerve stimulators market are Abbott Laboratories, Medtronic plc, Boston Scientific Corp., Globus Medical Inc., Livanova plc, Nevro Corp., Axonics Modulation Technologies, Saluda Medical Pty Ltd., Stimwave Technologies Incorporated, Nalu Medical Inc., Bioness Inc., SPR Therapeutics Inc., Neuspera Medical Inc., B. Braun Melsungen AG, NeuroMetrix Inc., BioElectronics Corporation, Soterix Medical Inc., Xavant Technology Pty Ltd., Neurostimulation Technologies, STIM Systems.

North America was the largest region in the peripheral nerve stimulators market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in peripheral nerve stimulators report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the peripheral nerve stimulators market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Peripheral nerve stimulators are medical devices designed to deliver electrical impulses to peripheral nerves, aiding in pain management or improving motor function. These devices are commonly used to treat chronic pain conditions, such as neuropathy, and to support the rehabilitation of patients with nerve injuries or disorders by stimulating nerve activity.

The main types of peripheral nerve stimulators include transcutaneous, percutaneous, and implantable devices. Transcutaneous Peripheral Nerve Stimulators (TENS) are non-invasive devices that deliver electrical impulses through the skin to block pain signals or stimulate the release of endorphins for pain relief. Additional devices in this category include stimulators, continuous peripheral nerve block (CPNB) catheters, and pain pumps. Peripheral nerve stimulators are available as disposable and rechargeable devices, with applications spanning hospitals, physiotherapy centers, ambulatory surgical centers, clinics, and other healthcare settings.

The peripheral nerve stimulators market research report is one of a series of new reports that provides peripheral nerve stimulators market statistics, including the peripheral nerve stimulators industry global market size, regional shares, competitors with the peripheral nerve stimulators market share, detailed peripheral nerve stimulators market segments, market trends, and opportunities, and any further data you may need to thrive in the peripheral nerve stimulators industry. This peripheral nerve stimulators market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The peripheral nerve stimulators market consists of sales of external peripheral nerve stimulators, implantable peripheral nerve stimulators, electrodes for nerve stimulation, and diagnostic stimulators. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.